Product logins

Find logins to all Clarivate products below.


Blog: Biopharma

Here you will find relevant articles and insight into all Clarivate related products and news.

The competitive signals hiding in plain sight for biopharma The competitive signals hiding in plain sight for biopharma
Blog May 8, 2026
The competitive signals hiding in plain sight for biopharma
Biopharma Business Development Clinical trials
Five lessons learned deploying agentic AI in the life sciences Five lessons learned deploying agentic AI in the life sciences
Blog April 30, 2026
Five lessons learned deploying agentic AI in the life sciences
AI
Target selection and safety assessment: Navigating early decisions that shape drug development Target selection and safety assessment: Navigating early decisions that shape drug development
Blog March 27, 2026
Target selection and safety assessment: Navigating early decisions that shape drug development
Development Pharma Regulatory
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
Blog March 26, 2026
Drugs to Watch 2026 Q&A: Lilly’s next-generation weight loss drugs
GLP-1 Metabolic
Why longevity might be biopharma's next big thing: The science and business converge Why longevity might be biopharma's next big thing: The science and business converge
Blog March 2, 2026
Why longevity might be biopharma's next big thing: The science and business converge
Gerontology
Why ease of administration in new drugs sometimes draws a yawn from payers Why ease of administration in new drugs sometimes draws a yawn from payers
Blog February 26, 2026
Why ease of administration in new drugs sometimes draws a yawn from payers
Biopharma Biotech Clinical trials
The path forward: What comes after a CRL? The path forward: What comes after a CRL?
Blog February 24, 2026
The path forward: What comes after a CRL?
Biopharma Biotech Clinical trials
Relacorilant:  when evidence meets the established evidence bar Relacorilant:  when evidence meets the established evidence bar
Blog February 24, 2026
Relacorilant: when evidence meets the established evidence bar
FDA Regulatory Safety

Biopharma

Combating COVID-19: Insights from the BIO Europe conference Combating COVID-19: Insights from the BIO Europe conference
Blog April 7, 2020
Combating COVID-19: Insights from the BIO Europe conference
Impact of COVID-19: 4 challenges life science companies face Impact of COVID-19: 4 challenges life science companies face
Blog April 3, 2020
Impact of COVID-19: 4 challenges life science companies face
Treating a pandemic: Drug repurposing, expanded access and emergency use authorization Treating a pandemic: Drug repurposing, expanded access and emergency use authorization
Blog March 31, 2020
Treating a pandemic: Drug repurposing, expanded access and emergency use authorization
The trials must go on: Conducting clinical studies during the COVID-19 pandemic The trials must go on: Conducting clinical studies during the COVID-19 pandemic
Blog March 31, 2020
The trials must go on: Conducting clinical studies during the COVID-19 pandemic
FDA to expedite public release of guidance documents related to COVID-19 FDA to expedite public release of guidance documents related to COVID-19
Blog March 31, 2020
FDA to expedite public release of guidance documents related to COVID-19
FDA unveils emergency investigational COVID-19 convalescent plasma application program FDA unveils emergency investigational COVID-19 convalescent plasma application program
Blog March 31, 2020
FDA unveils emergency investigational COVID-19 convalescent plasma application program
COVID-19: Scientific innovation will help us beat this virus COVID-19: Scientific innovation will help us beat this virus
Blog March 25, 2020
COVID-19: Scientific innovation will help us beat this virus
Information professionals: safeguard your day the Dialog solutions way! Information professionals: safeguard your day the Dialog solutions way!
Blog March 23, 2020
Information professionals: safeguard your day the Dialog solutions way!
COVID-19 testing: FDA guidance update COVID-19 testing: FDA guidance update
Blog March 11, 2020
COVID-19 testing: FDA guidance update
Biopharma M&A activity in Q4 2019 47% higher than in Q4 2018 Biopharma M&A activity in Q4 2019 47% higher than in Q4 2018
Blog March 10, 2020
Biopharma M&A activity in Q4 2019 47% higher than in Q4 2018